Literature DB >> 3569139

Nuclear 3,5,3'-triiodothyronine receptor occupancy, phosphoenolpyruvate carboxykinase (PEPck) messenger ribonucleic acid levels and PEPck enzyme activity in rat liver.

R Hartong, W M Wiersinga, W H Lamers.   

Abstract

The expression of the gene coding for phosphoenolpyruvate carboxykinase (PEPck) is under complex multi-hormonal control. A stimulatory effect of T3 on the expression of this gene has been described, but it has not been related to nuclear T3 receptor occupancy. We therefore studied simultaneously nuclear T3 receptor occupancy, PEPck enzyme activities, and PEPck messenger RNA (mRNA) levels in the liver of thyroidectomized, T3-treated rats. A dose-dependent increase in receptor occupancy and in enzyme activities was observed 24 h after a single ip injection of T3. However, no increase in the levels of PEPck mRNA was observed, using a specific complementary DNA (pPCK10). To evaluate this further, time-course experiments were performed over a 24 h period after a single ip injection of a receptor saturating dose of T3. These experiments showed simultaneous increases of PEPck enzyme activities and PEPck mRNA levels. Receptor occupancy had increased to 95% 3 h after injection of T3, whereas maximal levels of enzyme activity and mRNA were obtained 6-12 h after T3 administration. Translational efficiency did not change during induction. Twenty-four hours after T3 administration, mRNA levels and enzyme activity had declined, but receptor occupancy was still maximal. We conclude that T3 influences PEPck gene expression primarily at a pretranslational (transcriptional) level. The transient increase in PEPck mRNA despite persisting full receptor occupancy suggests a modification in time of the interaction between the T3-receptor complex and the regulatory region of the PEPck gene.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3569139     DOI: 10.1210/endo-120-6-2460

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  5 in total

1.  Developmental regulation of hepatic and renal gluconeogenic enzymes by thyroid hormones in fetal sheep during late gestation.

Authors:  Alison J Forhead; Kirsten R Poore; James Mapstone; Abigail L Fowden
Journal:  J Physiol       Date:  2003-03-14       Impact factor: 5.182

2.  Targeting thyroid hormone receptor-beta agonists to the liver reduces cholesterol and triglycerides and improves the therapeutic index.

Authors:  Mark D Erion; Edward E Cable; Bruce R Ito; Hongjian Jiang; James M Fujitaki; Patricia D Finn; Bao-Hong Zhang; Jinzhao Hou; Serge H Boyer; Paul D van Poelje; David L Linemeyer
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

3.  Sex differences of the influence of T3 on the topical distribution of phosphoenolpyruvate carboxykinase activity in the liver acinus.

Authors:  M Wimmer
Journal:  Histochemistry       Date:  1989

4.  Isolation of a cDNA clone encoding a biologically active thyroid hormone receptor.

Authors:  R J Koenig; R L Warne; G A Brent; J W Harney; P R Larsen; D D Moore
Journal:  Proc Natl Acad Sci U S A       Date:  1988-07       Impact factor: 11.205

5.  Regulation of phosphoenolpyruvate carboxykinase gene transcription by thyroid hormone involves two distinct binding sites in the promoter.

Authors:  E A Park; D C Jerden; S W Bahouth
Journal:  Biochem J       Date:  1995-08-01       Impact factor: 3.857

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.